Disposable Ostomy Bags Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Disposable Ostomy Bags Market Trends and Insights

Rising Colorectal Cancer and Inflammatory Bowel Disease Burden

The disposable ostomy bags market expands as cancer and chronic intestinal conditions increase the number of patients who may need ostomy surgery. Colorectal cancer accounted for 9.9% of new cancer cases worldwide in GLOBOCAN 2024^{[1]International Agency for Research on Cancer, “Global Cancer Statistics 2024,” International Agency for Research on Cancer}, ranking third for incidence and second for mortality. The World Health Organization projects nearly 35 million new cancer cases a year by 2050, 67% above the 2024 level. Better use of biologics, immunotherapy, and targeted treatments has extended survival for many colorectal cancer patients, increasing the importance of products used over long periods. Global inflammatory bowel disease prevalence reached 3.83 million cases in 2021 after rising 85.1% from 1990. China recorded 517,106 new colorectal cancer cases in 2022, and its expanding patient pool strengthens the need for ongoing self-management support 

Expansion of Home-Based Ostomy Management

Home-based management is a durable source of recurring demand in the disposable ostomy bags market. An estimated 750,000 to 1 million people in the United States use ostomy products, and close to 100,000 new ostomy surgeries occur annually. Specialized home health providers showed lower emergency room use and hospitalization than pharmacy-based care in an ISPOR 2025 study^{[2]ISPOR, “Enhanced Outcomes and Reduced Healthcare Utilization with Specialized Home Healthcare Service Providers for Ostomy and Urological Patients: Comparative Research with Pharmacy-Based Care,” ISPOR 2025}. This clinical and economic evidence supports payer decisions that direct patients toward supported home care. ConvaTec reported continued new patient starts through its Home Services Group in North America during 2025. A 2026 systematic review found that telehealth stoma care improved adjustment and self-efficacy, reinforcing the clinical systems that support patients outside hospitals 

Increasing Demand for Skin-Friendly and Leak-Resistant Designs

Skin protection is an important product choice factor in the disposable ostomy bags market because complications can affect comfort, confidence, and product use. A 2025 study found peristomal skin complications in 85% of intestinal stoma patients, including 35% mild, 18% moderate, and 32% severe cases. The study also linked these complications with lower mental well-being and health-related quality of life. In a 12-week clinical study, Coloplast SenSura Mio Convex Soft recorded leakage outside the baseplate on 2.2% of baseplates, compared with 7% for flat systems. Hollister uses a ceramide-containing barrier in its CeraPlus portfolio to address skin protection needs. Complications can increase replacement needs in the near term, but they also encourage patients and clinicians to move toward products with stronger skin-care features.

Digital Leakage Detection and Anatomy-Customized Pouching Systems

Digital systems are creating a higher-value product category within the disposable ostomy bags market. Coloplast’s Heylo digital leakage notification system received FDA 510(k) clearance on October 2025, for ileostomy and colostomy patients aged 12 and older. The Class I system uses Bluetooth-connected sensors and a smartphone application to identify baseplate leakage before a soiling event. A United Kingdom study reported an incremental cost-effectiveness ratio of GBP 110 per quality-adjusted life year and 49.81 fewer leakage episodes per person over 3 years. A German randomized trial involving 139 participants found a 31% reduction in leakage outside the baseplate. Hollister also received a U.S. patent for a double-sided sensor device for ostomy leak detection in November 2025. A 2026 modeling study showed how convex barrier properties interact with different abdominal profiles, supporting more individualized product selection. 

Peristomal Skin Complications and Product-Related Discomfort

Peristomal skin complications can raise replacement use but can also weaken confidence in ostomy appliances. Incidence estimates among patients with newly formed stomas ranged from 15.5% to 80%, while a 2025 Scientific Reports^{[3]Association of Chemotherapy and Stoma Features with Peristomal Skin Disorders, Scientific Reports} study found complications in 59.7% of patients 1 month after surgery. Patients may not recognize early changes in the skin, which increases reliance on trained wound, ostomy, and continence nurses. The uneven availability of these specialists can limit appropriate product fitting across regions. Product manufacturers must also support clinical evidence requirements for skin barriers and accessory devices under the European Union Medical Device Regulation 2017/745. These factors can increase development effort and slow the introduction of differentiated products.

High Cost of Premium Multi-Piece Systems and Accessories

Higher-priced multi-piece systems can restrict access in price-sensitive parts of the disposable ostomy bags market. The original evidence indicates that long-term pouching, adhesive, and accessory spending represent most stoma-care expenditure for permanent colostomy patients. Two-piece convex systems cost more per appliance than one-piece closed-end options, limiting uptake where patients pay directly. This issue is most relevant in Latin America, Southeast Asia, and sub-Saharan Africa. The United Ostomy Associations of America stated in January 2026 that Medicare competitive bidding for ostomy supplies is scheduled to begin in 2028. Manufacturers may need product tiers that retain premium features while offering lower-cost options for tender-based channels.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Product Type: One-Piece Systems Lead, Two-Piece Gains Clinical Momentum

One-piece systems held 63.4% of the disposable ostomy bags market share in 2025. Their position reflects straightforward application, a lower profile, and easier daily management for home-care users. These features also suit many older patients and people who are learning self-care after surgery. One-piece products are supported by their lower cost in reimbursement-limited settings. This established base keeps the format central to the disposable ostomy bags market.

Two-piece systems are forecast to grow at a 6.8% CAGR through 2031. Their main benefit is that users can change the pouch without removing the baseplate. This can reduce repeated skin disturbance for patients managing peristomal skin problems. Coloplast^{[4]Coloplast A/S, “Announcement no. 05/2026: Interim Financial Report H1 2025/26,” GlobeNewswire} continued to add accounts for its SenSura Mio two-piece offering in Europe and the United States through the first half of 2025/26. Telehealth consultations can also help clinicians review baseplate fit and recommend pouch-only changes, which favors modular systems.

By Ostomy Type: Colostomy’s Scale Holds Firm as Urostomy Accelerates

Colostomy bags accounted for 52.8% of revenue in the disposable ostomy bags market in 2025. Their scale follows the close relationship between colorectal cancer surgery and the creation of temporary or permanent colostomies. Colorectal cancer remains one of the most common cancers worldwide, with an estimated 2 million new cases annually. The disposable ostomy bags industry relies on recurring use because many patients require ongoing management after surgery. Colostomy products, therefore, remain the core volume category.

Urostomy bags have the highest projected growth rate at 7.2% through 2031. Rising bladder cancer surgery volumes increase the need for urinary diversion products. Urinary diversions also have a lower reversal rate than intestinal ostomies, which extends the period of product use. Ileostomy bags maintain demand from Crohn’s disease and ulcerative colitis procedures. Inflammatory bowel disease rates are rising in areas that previously had lower disease burdens, including Southeast Asia and Latin America. Younger bladder cancer patients in parts of Asia may also raise demand for products that support active lifestyles.

By System Design: Drainable Systems Anchor Volumes, Convex Designs Rewrite Clinical Expectations

Drainable systems held 46.7% of revenue in the disposable ostomy bags market in 2025. They are suitable for ileostomy and high-output colostomy patients who need to empty pouches often. Their established use makes them a key volume category for healthcare providers and home-care patients. Flat and closed-end systems still serve patients with formed and predictable output. However, the disposable ostomy bags market is moving toward designs that address individual stoma and body profiles.

Convex systems are expected to expand at an 8.4% CAGR through 2031. They are used for retracted, flush, or soft-peristomal-tissue stomas, where better contact can reduce leakage. The clinical results for SenSura Mio Convex Soft give nurses a documented reason to recommend convex products. The 2026 computer model of barrier convexity and abdominal profiles may support more specific product matching. This could further shift demand from standard flat systems toward anatomy-responsive designs.

By Indication: Colorectal Cancer Retains Scale, IBD Opens a Faster Growth Corridor

Colorectal cancer held 48.9% share of the disposable ostomy bags market size in 2025. The segment reflects the well-established need for ostomy creation in surgical cancer management. Some patients use an ostomy temporarily, while others require long-term support. The large global colorectal cancer burden maintains a consistent procedure base. This indicates the leading source of demand in the disposable ostomy bags market.

Inflammatory bowel disease is projected to grow at a 7.8% CAGR through 2031. The condition affects a growing group of patients who are often younger and focused on discretion, wear time, and mobility. Its prevalence growth is creating new patient pools in Asia, the Middle East, and Africa. Bladder cancer and urinary diversion products carry higher unit prices because of specialized care requirements. Diverticulitis, gastrointestinal trauma, and fistula management contribute steadier volumes with more standardized product requirements.

By End User: Home-Care Settings Drive Both Share and Speed

Home-care settings held 54.2% of the disposable ostomy bags market share in 2025. They are also forecast to grow at an 8.7% CAGR through 2031. This combination reflects patient preference, payer economics, and wider use of remote support. The disposable ostomy bags market benefits when patients can receive training and supplies at home. Evidence from ISPOR supports lower healthcare use under specialized home health support 

Hospitals and specialty clinics remain important for early post-surgical treatment and nurse-led training. Their product choices can influence what patients continue to use after discharge. Ambulatory surgical centers are becoming more relevant as planned reversals and elective procedures move away from inpatient settings. Long-term care facilities need easy-to-apply one-piece systems for older patients who cannot manage products independently. Specialist ostomy clinics have lower direct purchasing volume but can strongly influence product selection through patient trials and training.

Geography Analysis

North America held 41.8% of revenue in the disposable ostomy bags market in 2025. The region has a large insured patient base, including an estimated 750,000 to 1 million people with permanent or temporary ostomies in the United States. Medicare Part B supports a stable reimbursement foundation for ostomy supplies. The United Ostomy Associations of America stated that supplies remain covered and that competitive bidding is scheduled for 2028. Premium convex and two-piece products have strong regional uptake.

Asia-Pacific is forecast to grow at a 7.5% CAGR through 2031, the fastest regional rate in the disposable ostomy bags market. China’s colorectal cancer burden, India’s hospital expansion, and Japan’s older population support regional demand. China has more than 1 million ostomy patients, with close to 100,000 new patients each year according to the source material. Japan combines an aging population with established reimbursement for stoma-care products, while South Korea, Australia, and New Zealand have well-developed branded product markets.

Europe has a substantial stoma population and established reimbursement structures, with Germany leading regional volumes. Coloplast reported double-digit growth in the United Kingdom during the first half of 2025/26, supported by SenSura Mio Convex. South America is led by Brazil as colorectal cancer treatment access improves. ConvaTec identified Latin America as a growth leader in its April 2026 trading update. The Middle East and Africa remain earlier-stage areas with rising awareness and more private hospital capacity.